- Home
- SST vs ABVC Comparison
SST vs ABVC Comparison
Compare SST & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- ABVC
- Stock Information
- Founded
- SST 2013
- ABVC 2015
- Country
- SST United States
- ABVC United States
- Employees
- SST N/A
- ABVC N/A
- Industry
- SST Diversified Commercial Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- ABVC Health Care
- Exchange
- SST Nasdaq
- ABVC Nasdaq
- Market Cap
- SST 57.3M
- ABVC 52.1M
- IPO Year
- SST N/A
- ABVC N/A
- Fundamental
- Price
- SST $7.57
- ABVC $2.75
- Analyst Decision
- SST Strong Buy
- ABVC
- Analyst Count
- SST 1
- ABVC 0
- Target Price
- SST $10.00
- ABVC N/A
- AVG Volume (30 Days)
- SST 51.7K
- ABVC 121.2K
- Earning Date
- SST 11-06-2025
- ABVC 08-13-2025
- Dividend Yield
- SST N/A
- ABVC N/A
- EPS Growth
- SST N/A
- ABVC N/A
- EPS
- SST N/A
- ABVC N/A
- Revenue
- SST $317,055,000.00
- ABVC $391,242.00
- Revenue This Year
- SST N/A
- ABVC $735.18
- Revenue Next Year
- SST $12.20
- ABVC N/A
- P/E Ratio
- SST N/A
- ABVC N/A
- Revenue Growth
- SST N/A
- ABVC 186.84
- 52 Week Low
- SST $2.90
- ABVC $0.40
- 52 Week High
- SST $15.00
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- SST 58.58
- ABVC 46.00
- Support Level
- SST $6.62
- ABVC $2.51
- Resistance Level
- SST $7.90
- ABVC $3.14
- Average True Range (ATR)
- SST 0.83
- ABVC 0.21
- MACD
- SST 0.06
- ABVC -0.04
- Stochastic Oscillator
- SST 71.10
- ABVC 28.40
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.